ATG12 and neoplasm: GBCDRlnc1 interacts with PGK1 protein, inhibits its ubiquitination and degradation, increases the expression of ATG5‐ATG12 conjugate as a downstream target, promotes tumour cell autophagy and induces DOX resistance.37, 38